QTTB

Russell 2000 below the 200-day average

Overview →

QTTB News

About

homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.

Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Arthur Tzianabos
Leadership (7)
Elham HershbergerChief Development Officer
José TrevejoChief Medical Officer
Shelia VioletteCo-founder, Chief Scientific Officer & President of Research
Lee H. KalowskiChief Financial Officer & President
David AppuglieseSenior Vice President & Head of People
Jodie Pope MorrisonChief Executive Officer & Director
Maria MarzilliChief Business Officer
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.